STATUS OF ORPHAN DRUGS AND REIMBURSEMENT RECOMMENDATIONS AND DECISIONS IN ANALYSED EUROPEAN COUNTRIES

被引：0
|
作者：
Kawalec, P. [1 ]
Malinowski, K. [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Krakow, Poland
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1450
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY133
引用
收藏
页码：A598 / A599
页数：2
相关论文
共 50 条
  • [21] THE REIMBURSEMENT OF EXPENSIVE DRUGS IN HOSPITALS IN WESTERN EUROPEAN COUNTRIES
    Falk, K.
    Brown, A.
    Murray, G.
    Martensson, M.
    VALUE IN HEALTH, 2014, 17 (07) : A428 - A429
  • [22] Rare diseases and orphan drugs in Eastern European Countries
    Stefanov, Rumen
    Taruscio, Domenica
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2009, 6 (04): : 289 - 293
  • [23] INTER-COUNTRY VARIABILITY IN COVERAGE DECISIONS FOR ORPHAN DRUGS: CRITERIA DRIVING HTA RECOMMENDATIONS IN SIX COUNTRIES
    Nicod, E.
    Kanavos, P.
    VALUE IN HEALTH, 2013, 16 (03) : A3 - A3
  • [24] Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework
    Paulden, Mike
    Stafinski, Tania
    Menon, Devidas
    McCabe, Christopher
    PHARMACOECONOMICS, 2015, 33 (03) : 255 - 269
  • [25] Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework
    Mike Paulden
    Tania Stafinski
    Devidas Menon
    Christopher McCabe
    PharmacoEconomics, 2015, 33 : 255 - 269
  • [26] COMPARATIVE ANALYSIS OF HTA DECISIONS, PRICE AND REIMBURSEMENT LEVEL OF ORPHAN DRUGS IN FRANCE AND ITALY
    Korchagina, D.
    Tavella, F.
    Remuzat, C.
    Kornfeld, A.
    Toumi, M.
    VALUE IN HEALTH, 2014, 17 (07) : A539 - A540
  • [27] Pricing and reimbursement of orphan drugs in Italy
    Lopatriello, S.
    Schivazappa, C.
    Negrini, C.
    Berto, P.
    VALUE IN HEALTH, 2006, 9 (06) : A208 - A209
  • [28] REIMBURSEMENT OF ORPHAN DRUGS: WHAT IS THE DIFFERENCE?
    Mueller, E.
    Schmidt, E.
    Ehreth, J.
    VALUE IN HEALTH, 2012, 15 (07) : A311 - A311
  • [29] THE REIMBURSEMENT OF ORPHAN DRUGS ACROSS EUROPE
    Nixon, F.
    VALUE IN HEALTH, 2008, 11 (06) : A375 - A376
  • [30] PRICING AND REIMBURSEMENT OF ORPHAN DRUGS IN CANADA
    Kumar, J.
    Bachman, E. M.
    VALUE IN HEALTH, 2011, 14 (03) : A29 - A29
12345